ResearcherHuai'an Hospital of Huai'an CityActive in the last 2 years

Lingling Zeng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5036128547. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Pro-inflammatory dietary patterns and their association with cardiovascular disease and pancreatic cancer in a hospital population: a cross-sectional study. Last author DOI 10.3389/fnut.2025.1666682 ↗
Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1236435 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qiangsong Jin · 1 shared paper, 2025 · strength 0.30
- Paper Pro-inflammatory dietary patterns and their association with cardiovascular disease and pancreatic cancer in a hospital… DOI 10.3389/fnut.2025.1666682 ↗
Feng Liang · 1 shared paper, 2025 · strength 0.30
- Paper Pro-inflammatory dietary patterns and their association with cardiovascular disease and pancreatic cancer in a hospital… DOI 10.3389/fnut.2025.1666682 ↗
Qi Wang · 1 shared paper, 2023 · strength 0.17
- Paper Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal a… DOI 10.3389/fonc.2023.1236435 ↗
Bicheng Ye · 1 shared paper, 2023 · strength 0.17
- Paper Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal a… DOI 10.3389/fonc.2023.1236435 ↗
Jingen Xie · 1 shared paper, 2023 · strength 0.17
- Paper Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal a… DOI 10.3389/fonc.2023.1236435 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.